These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19894100

  • 1. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.
    Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, Fritzsche D, Schäuble B, TOPMATMIG-0001 investigators.
    J Headache Pain; 2010 Feb; 11(1):33-44. PubMed ID: 19894100
    [Abstract] [Full Text] [Related]

  • 2. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 Feb; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 3. Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
    Malessa R, Gendolla A, Steinberg B, Schmitt L, Bornhoevd K, Djelani M, Schäuble B, TOPMAT-MIG-3004 investigators.
    Curr Med Res Opin; 2010 May; 26(5):1119-29. PubMed ID: 20225996
    [Abstract] [Full Text] [Related]

  • 4. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 6. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 7. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 8. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Oct 04; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 9. Migraines with and without aura and their response to preventive therapy with topiramate.
    Reuter U, Sanchez Del Rio M, Diener HC, Allais G, Davies B, Gendolla A, Pfeil J, Schwalen S, Schäuble B, van Oene J.
    Cephalalgia; 2010 May 04; 30(5):543-51. PubMed ID: 19732072
    [Abstract] [Full Text] [Related]

  • 10. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 May 04; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 11. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar 04; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D, Paradiso E.
    Headache; 2007 Mar 04; 47(10):1409-17. PubMed ID: 18052950
    [Abstract] [Full Text] [Related]

  • 13. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J, Campos J, Casas C, Herranz JL.
    J Child Neurol; 2005 Mar 04; 20(3):251-3. PubMed ID: 15832623
    [Abstract] [Full Text] [Related]

  • 14. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials.
    Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J.
    CNS Spectr; 2003 Jun 04; 8(6):428-32. PubMed ID: 12858132
    [Abstract] [Full Text] [Related]

  • 15. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun 04; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 16. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 04; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 17. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 18. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug 25; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 19. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Aug 25; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 20. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Aug 25; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.